HPLC using a gradient of H2O (from 70 to 85%) in MeCN.
Bound proteins were eluted by using a gradient of imidazole (0 500 mM) with a total volume of 50 mL.
Chromatography was performed on a C18 column using a gradient of acetonitrile in water as a mobile phase.
Using a gradient of acetonitrile in 0.05 % (w/w) trifluoroacetic acid, the LC system Schimazu 10A vp was used and the consecutive assay from 200 to 600 nm.
Subfraction II-2-5 was refined by a preparative C18 HPLC column using a gradient of MeCN H2O (45:55–60:40, v/v).
It provided robust and high quality separation of the compounds within a 2 min timeframe, using a gradient of ethanol as co-solvent of the carbon dioxide.
We address this using a robust before-and after logging experimental design in the before-and after, using a gradient of logging intexperimentalredesignwo dinferenthepatial scales.
C18 HPLC using a gradient of MeCN H2O (55:45–70:30, v/v) which afforded 6.7 mg of 6. Fraction II-4-3 wasubjecteded to a prep.
A small amount of the test compound (6 7 mg) was weighed into the measuring crucible and heated using a controlled temperature program between 25 and 700 °C using a gradient of 10 °C min−1.
Acidic proteins including DMP1 were extracted from whole brain and applied to a Q-Sepharose column to purify the DMP1 components by using a gradient of NaCl (0.1 to 1.2 mol/L).
After 10 min, the product was purified by semi-preparative HPLC using a gradient of 0%to40%0% MeCN in 6 min and was obtained as a white solid upon lyophilization (13.8 mg, 2.8 μmol, 89%).
